We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current QLGN market cap is 1.87M. The company's latest EPS is USD -1.1038 and P/E is -0.41.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.63M | 0 | 0 | 0 | 0 |
| Operating Income | -3.55M | -1.15M | -2.27M | -1.42M | -1.75M |
| Net Income | -3.46M | -3.66M | -2.45M | -2.03M | -1.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 2.85M | 5.65M | 4.98M | 0 |
| Operating Income | -10.84M | -11.9M | -22.66M | -22.18M | -11.31M |
| Net Income | -10.13M | -19.55M | -17.9M | -18.64M | -13.42M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.15M | 4.32M | 2.03M | 1M | 534k |
| Total Liabilities | 9.84M | 5.96M | 4.14M | 4.53M | 4.81M |
| Total Equity | 3.31M | -1.64M | -2.1M | -3.52M | -4.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.8M | 29.13M | 22.84M | 19.08M | 2.03M |
| Total Liabilities | 1.7M | 10.83M | 6.27M | 10.32M | 4.14M |
| Total Equity | 1.1M | 18.3M | 16.57M | 8.77M | -2.1M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.56M | -4.63M | -10.3M | -784k | -2.26M |
| Investing | -246k | 3.98M | 4.22M | N/A | 350k |
| Financing | N/A | -440k | -550k | 475k | 1.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.52M | -10.16M | -14.73M | -13.25M | -10.3M |
| Investing | 7M | -64k | -141k | -184k | 4.22M |
| Financing | 1.41M | 34.05M | 8.43M | 2.91M | -550k |
| Market Cap | 1.87M |
| Price to Earnings Ratio | -0.41 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 13.6 |
| Price to Book Ratio | -2.6 |
| Dividend Yield | - |
| Shares Outstanding | 12.16M |
| Average Volume (1 week) | 499.53k |
| Average Volume (1 Month) | 318.94k |
| 52 Week Change | -84.75% |
| 52 Week High | 1.10 |
| 52 Week Low | 0.141 |
| Spread (Intraday) | 0.06 (28.33%) |
| Company Name | Qualigen Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.qualigeninc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
